Skip to content

Optima Coil System OPTI0509CSF10 (REF N/A)Recalls & reported problems

Balt USA LLC · The Optima Coil System is indicated for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations (AVMs) and arteriovenous fistulae. The Optima Coil System is also indicated for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolization in the peripheral vasculature. The Optima Coil System comprises of implant coil and a pusher assembly. The Optima Coil System is designed fr use with the XCEL Detachment Controller. The Optima coil is detached thermally with the XCEL Detachment Controller. · Class 2 · Implant

All models of Optima Coil System (379)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
2

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818053026140), received between Mar 28, 2025 and Mar 28, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Migration” (1 report).

2 FDA recall records name this device's identifier, 2 still open.

2 other recalls cover devices cleared under the same FDA submission (K172390); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. May 8, 2025Open, Classified

    Due to radiopaque (RO) marker was not visible during angiography and it was determined that the RO marker was not manufactured to specification.

    Z-1988-2025 · Root cause: Vendor change control · Recall details · FDA record ↗

  2. Jan 3, 2024Open, Classified

    Discoloration was identified along the delivery pusher which was attributed to corrosion of the hypotube. The material which caused the corrosion was identified as remnants of solder flux residue remaining on the hypotube component of the delivery pusher. Due to the location of the delivery pusher within the delivery system, it is possible for the discoloration to mechanically break off from the delivery pusher, leaving the potential for the material to flow through the delivery system (i.e. microcatheter), and into the patient vasculature causing foreign emboli.

    Z-1041-2024 · Root cause: Material/Component Contamination · Recall details · FDA record ↗

Most reported problems

Device problems

  • Migration1
  • Premature Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 28, 2025Migration; Premature Separation; Migration; Premature Separation

    IT WAS REPORTED THAT: "PATIENT INFORMATION: SEX: UNKNOWN DISEASE NAME: 5MM ANEURYSM IN A-COM, PROCEDURE: PLANNED PROCEDURE, GUIDING CATHETER: ESPERANCE DISTAL ACCESS CATHETER/JAPAN LIFELINE Y CONNECTOR: UNKNOWN, USED COILS, MICROCATHETER, AND ASSIST STENT: 1. OPTIMA SOFT 5X9 (LOT# F210900201) (IT WILL BE REPORTED AS YA2024-1268.) 2. OPTIMA SOFT 5X9 (LOT# F210800307), SL-10 45°(IT WILL BE REPORTED AS YA2024-1269.) 3. OPTIMA SS 4X8 (LOT# UNKNOWN), SL-10 STRAIGHT. 4. OPTIMA SS 4X8 (LOT# UNKNOWN), SL-10 STRAIGHT. 5. OPTIMA SS 2.5X4 (LOT# UNKNOWN), SL-10 STRAIGHT. 6. OPTIMA SS 1.5X2 (LOT# UNKNOWN), SL-10 STRAIGHT. NEUROFORM ATLAS STENT SYSTEM 3X21/STRYKER. DESCRIPTION: THE PROCEDURE WAS PERFORMED ON AN ANEURYSM OF THE A-COM. AN ATTEMPT WAS MADE TO USE THE OPTIMA SOFT 5X9 (LOT# F210900201) AS THE FIRST COIL, BUT IT WAS DIFFICULT TO ADVANCE WITHIN THE INTRODUCER SHEATH, AND THE PHYSICIAN FELT DISCOMFORT. THEREFORE, A NEW OPTIMA SOFT5X9 (LOT# F210800307) OF THE SAME SIZE WAS PREPARED, AND THE PROCEDURE WAS CONTINUED. (IT WILL BE REPORTED AS YA2024-1268.) FOR AN ANEURYSM AT THE A-COM, EMBOLIZATION WAS ATTEMPTED USING A DOUBLE CATHETER TECHNIQUE WITH THE MICROCATHETERS SL-10 45° AND SL-10 ST

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21721467 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K172390. One submission often covers many models, so check the product and lot details in each record.

  • Z-0103-2023 · Sep 7, 2022 · Open, Classified
    Optima Coil System Model Number OPTI0208CSS10, Model Number OPTI0308CSS10. Used in endovascular procedures.
  • Z-1680-2022 · Jul 26, 2022 · Open, Classified
    Optima Coil System Model OPTI0520CSF10. For endovascular embolization.

Other Device, Neurovascular Embolization devices

All Device, Neurovascular Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page